After the shutdown and continuing investigation of New England Compounding Pharmacy, responsible for the nationwide fungal meningitis outbreak which has caused over 344 illnesses and 25 deaths, another compounding pharmacy has been shut down.
In fact, the compounding pharmacy that was recently called into question also is located in Massachusetts. Infusion Resource in Waltham reportedly surrendered its license to the Massachusetts Public Health Department’s Bureau of Health Care Safety and Quality. This came after state officials conducted a surprise inspection of the pharmacy, which led to questionable findings regarding the sterility of its products.
After mold and bacteria were found at New England Compounding Pharmacy, Governor Deval Patrick directed the state’s Board of Registration in Pharmacy to begin unannounced inspections of compounding pharmacies that make sterile, injectable medications. This is why Infusion Resource was recently inspected, as it is one of the 25 compounding pharmacies in Massachusetts that prepare this type of medication.
Inspectors who visited this compounding pharmacy found troubling discoveries that led to the immediate cease-and-desist order. As of now, there is no evidence of contaminated drugs, but intravenous medications which are against state regulations were prepared there.
Dr. Lauren Smith, the interim commissioner of the Massachusetts Department of Public Health, said the state’s goal is to inspect all of the compounding pharmacies by January 1, 2013 and the department is bringing on five new inspectors to assist with conducting unannounced visits.
Infusion Resource was last inspected by the state when it opened in December 2009. There have been no complaints about the pharmacy since its opening.
As pharmacy error lawyers, we will keep monitoring this situation involving compounding pharmacies.